Chronic effects of Brahmi (Bacopa monnieri)
on human memory
by
Roodenrys S, Booth D, Bulzomi S,
Phipps A, Micallef C, Smoker J.
Department of Psychology,
University of Wollongong,
Woolongong, Australia.
steven_roodenrys@uow.edu.au
Neuropsychopharmacology. 2002 Aug;27(2):279-81

ABSTRACT

A study is reported on the effects of Brahmi (Bacopa monniera) on human memory. Seventy-six adults aged between 40 and 65 years took part in a double-blind randomized, placebo control study in which various memory functions were tested and levels of anxiety measured. There were three testing sessions: one prior to the trial, one after three months on the trial, and one six weeks after the completion of the trial. The results show a significant effect of the Brahmi on a test for the retention of new information. Follow-up tests showed that the rate of learning was unaffected, suggesting that Brahmi decreases the rate of forgetting of newly acquired information. Tasks assessing attention, verbal and visual short-term memory and the retrieval of pre-experimental knowledge were unaffected. Questionnaire measures of everyday memory function and anxiety levels were also unaffected.

Bacopa monniera
The memory switch?
Dumb-drug euphoria
Growing new brain cells
Bacopa monniera and bacosides

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Utopian Pharmacology
SMART DRUGS 2: review
The Hedonistic Imperative
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family